Annual D&A
$29.00 K
-$14.00 K-32.56%
December 31, 2023
Summary
- As of February 12, 2025, AKRO annual depreciation & amortization is $29.00 thousand, with the most recent change of -$14.00 thousand (-32.56%) on December 31, 2023.
- During the last 3 years, AKRO annual D&A has risen by +$12.00 thousand (+70.59%).
- AKRO annual D&A is now -32.56% below its all-time high of $43.00 thousand, reached on December 31, 2022.
Performance
AKRO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1000.00
$0.000.00%
September 30, 2024
Summary
- As of February 12, 2025, AKRO quarterly depreciation & amortization is $1000.00, unchanged on September 30, 2024.
- Over the past year, AKRO quarterly D&A has dropped by -$4000.00 (-80.00%).
- AKRO quarterly D&A is now -90.91% below its all-time high of $11.00 thousand, reached on December 31, 2020.
Performance
AKRO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$5000.00
-$4000.00-44.44%
September 30, 2024
Summary
- As of February 12, 2025, AKRO TTM depreciation & amortization is $5000.00, with the most recent change of -$4000.00 (-44.44%) on September 30, 2024.
- Over the past year, AKRO TTM D&A has dropped by -$32.00 thousand (-86.49%).
- AKRO TTM D&A is now -88.64% below its all-time high of $44.00 thousand, reached on September 30, 2022.
Performance
AKRO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
AKRO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.6% | -80.0% | -86.5% |
| 3 y3 years | +70.6% | -88.9% | -87.8% |
| 5 y5 years | - | +100.0% | +100.0% |
AKRO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.6% | at low | -90.9% | at low | -88.6% | at low |
| 5 y | 5-year | -32.6% | -100.0% | -90.9% | -100.0% | -88.6% | -100.0% |
| alltime | all time | -32.6% | -100.0% | -90.9% | -100.0% | -88.6% | -100.0% |
Akero Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1000.00(0.0%) | $5000.00(-44.4%) |
| Jun 2024 | - | $1000.00(0.0%) | $9000.00(-52.6%) |
| Mar 2024 | - | $1000.00(-50.0%) | $19.00 K(-34.5%) |
| Dec 2023 | $29.00 K(-32.6%) | $2000.00(-60.0%) | $29.00 K(-21.6%) |
| Sep 2023 | - | $5000.00(-54.5%) | $37.00 K(-14.0%) |
| Jun 2023 | - | $11.00 K(0.0%) | $43.00 K(0.0%) |
| Mar 2023 | - | $11.00 K(+10.0%) | $43.00 K(0.0%) |
| Dec 2022 | $43.00 K | $10.00 K(-9.1%) | $43.00 K(-2.3%) |
| Sep 2022 | - | $11.00 K(0.0%) | $44.00 K(+4.8%) |
| Jun 2022 | - | $11.00 K(0.0%) | $42.00 K(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $11.00 K(0.0%) | $41.00 K(0.0%) |
| Dec 2021 | $41.00 K(+141.2%) | $11.00 K(+22.2%) | $41.00 K(0.0%) |
| Sep 2021 | - | $9000.00(-10.0%) | $41.00 K(+7.9%) |
| Jun 2021 | - | $10.00 K(-9.1%) | $38.00 K(+35.7%) |
| Mar 2021 | - | $11.00 K(0.0%) | $28.00 K(+64.7%) |
| Dec 2020 | $17.00 K(>+9900.0%) | $11.00 K(+83.3%) | $17.00 K(+183.3%) |
| Sep 2020 | - | $6000.00(>+9900.0%) | $6000.00(>+9900.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00 | $0.00 |
FAQ
- What is Akero Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Akero Therapeutics?
- What is Akero Therapeutics annual D&A year-on-year change?
- What is Akero Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Akero Therapeutics?
- What is Akero Therapeutics quarterly D&A year-on-year change?
- What is Akero Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Akero Therapeutics?
- What is Akero Therapeutics TTM D&A year-on-year change?
What is Akero Therapeutics annual depreciation & amortization?
The current annual D&A of AKRO is $29.00 K
What is the all time high annual D&A for Akero Therapeutics?
Akero Therapeutics all-time high annual depreciation & amortization is $43.00 K
What is Akero Therapeutics annual D&A year-on-year change?
Over the past year, AKRO annual depreciation & amortization has changed by -$14.00 K (-32.56%)
What is Akero Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of AKRO is $1000.00
What is the all time high quarterly D&A for Akero Therapeutics?
Akero Therapeutics all-time high quarterly depreciation & amortization is $11.00 K
What is Akero Therapeutics quarterly D&A year-on-year change?
Over the past year, AKRO quarterly depreciation & amortization has changed by -$4000.00 (-80.00%)
What is Akero Therapeutics TTM depreciation & amortization?
The current TTM D&A of AKRO is $5000.00
What is the all time high TTM D&A for Akero Therapeutics?
Akero Therapeutics all-time high TTM depreciation & amortization is $44.00 K
What is Akero Therapeutics TTM D&A year-on-year change?
Over the past year, AKRO TTM depreciation & amortization has changed by -$32.00 K (-86.49%)